Home
Scholarly Works
Low-molecular-weight heparins are superior to...
Journal article

Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review

Authors

Akl EA; Barba M; Rohilla S; Terrenato I; Sperati F; Muti P; Schünemann HJ

Journal

Journal of Experimental & Clinical Cancer Research, Vol. 27, , pp. 21–21

Publication Date

October 6, 2008

Associated Experts

Elie Akl

Associate Professor (Part-Time), Faculty of Health Sciences
Visit profile

Holger Schunemann

Professor Emeritus, Faculty of Health Sciences
Visit profile

Paola Muti

Professor Emeritus, Faculty of Health Sciences
Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences3211 Oncology and carcinogenesis

Medical Subject Headings (MeSH)

AnticoagulantsHeparin, Low-Molecular-WeightHumansNeoplasmsRandomized Controlled Trials as TopicVenous ThromboembolismVitamin K

Contact the Experts team

Get technical help
or
Provide website feedback